home / stock / alny / alny articles

ALNY Articles, Alnylam Pharmaceuticals Inc. - From 10/17/23

Stock Information
Company Name: Alnylam Pharmaceuticals Inc.
Stock Symbol: ALNY
Market: NASDAQ
Website: alnylam.com
Menu
ALNY ALNY Quote ALNY Short ALNY News ALNY Articles ALNY Message Board
Get ALNY Alerts

News, Short Squeeze, Breakout and More Instantly...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Alnylam Pharmaceuticals, Inc. | Benzinga

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceut...
CSX To Rally Around 27%? Here Are 10 Other Analyst Forecasts For Wednesday | Benzinga

Morgan Stanley cut Netflix, Inc. (NASDAQ: NFLX) price target from $450 to $430. Morgan Stanley analyst Benjamin Swinburne maintained an Equal-We...

Why Is Genetic Disease-Focused Alnylam Pharmaceuticals Stock Trading Lower Today? | Benzinga

The FDA has issued a Complete Response Letter (CRL) to Alnylam Pharmaceuticals Inc's (NASDAQ: ALNY) supplemental New Drug Application...

Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges | Benzinga

Ionis Pharmaceuticals Inc (NASDAQ: IONS) entered an agreement with Roche Holdings AG (OTC: RHHBY) for two undisclosed early-sta...
Potential Label Restrictions Loom For Alnylam's Patisiran Despite Approval Prospects | Benzinga

On Wednesday, an FDA advisory committee voted 9-3 in favor of Alnylam Pharmaceuticals Inc's (NASDAQ: ALNY) patisiran. It has a favora...

S&P 500 Reclaims 4,500, Oil Hits $90 As Rising Inflation Fails To Dampen Risk Sentiment: What's Driving Markets Thursday? | Benzinga

Thursday witnessed a widespread rally across the spectrum of risk markets, with both equities and commodities surging in response to a slew of econ...

Despite FDA Doubts, Adcomm Backs Alnylam's Gene Silencing Therapy For Expanded Use Into Rare Heart Disease | Benzinga

On Wednesday, an FDA advisory committee voted 9-3 in favor of Alnylam Pharmaceuticals Inc's (NASDAQ: ALNY) patisiran. It has a favora...
Nasdaq, S&P 500 Futures In Green As Traders Look Past Inflation Data; Analyst Singles Out Key Catalyst That Can Keep Year's Rally Going | Benzinga

With inflation data in the rearview mirror, traders could be prepping to resume buying ways, with stock index futures pointing to a higher opening ...

Here's How Much $1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today | Benzinga

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 5 years by 6.92% on an annualized basis producing an average annual...

Cramer Says 'Please Stay Away' From This EV Maker, It 'Should Not Be Public' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norfolk Southern Corporation (NYSE: NSC) is the "cheapest I’ve ...
Previous 10 Next 10